• Tidak ada hasil yang ditemukan

LAMPIRAN - Repository UNISBA

N/A
N/A
Protected

Academic year: 2023

Membagikan "LAMPIRAN - Repository UNISBA"

Copied!
11
0
0

Teks penuh

(1)

LAMPIRAN

Lampiran 1 Dokumentasi penelitian

Gambar 1. Mencukur Rambut Tikus Gambar 2. Tikus Sesudah Dicukur

Gambar 3. Pengukuran Luka Insisi Gambar 4. Proses Insisi

Gambar 5. Tikus Sesudah Diinsisi Gambar 6. Terapi dengan Bubuk Kopi

Gambar 7. Luka Setelah Diberi Bubuk Kopi

Gambar 8. Terapi Menggunakan

Neomisin-Basitrasin

(2)

Lampiran 2 Persetujuan Etik

(3)

Lampiran 3 Data Penelitian Crosstabs

Case Processing Summary Cases

Valid Missing Total

N Percent N Percent N Percent

oozingH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%

oozingH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%

oozingH7 * Kelompok Crosstabulation

Kelompok Total

Serbuk Kopi Robusta

Serbuk Basitracin

Kontrol

oozingH7

Permukaan Basah

Count 0 1 0 1

% within Kelompok

0,0% 20,0% 0,0% 6,7%

Permukaan Basah Berkurang

Count 0 0 5 5

% within Kelompok

0,0% 0,0% 100,0% 33,3%

Permukaan Kering

Count 5 4 0 9

% within Kelompok

100,0% 80,0% 0,0% 60,0%

Total

Count 5 5 5 15

% within Kelompok

100,0% 100,0% 100,0% 100,0%

oozingH14 * Kelompok Crosstabulation

Kelompok Total

Serbuk Kopi Robusta

Serbuk Basitracin

Kontrol

oozingH14 Permukaan Kering

Count 5 5 5 15

% within Kelompok

100,0% 100,0% 100,0% 100,0%

Total

Count 5 5 5 15

% within Kelompok

100,0% 100,0% 100,0% 100,0%

(4)

Crosstabs

Case Processing Summary Cases

Valid Missing Total

N Percent N Percent N Percent

tepiH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%

tepiH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%

tepiH7 * Kelompok Crosstabulation

Kelompok Total

Serbuk Kopi Robusta

Serbuk Basitracin

Kontrol

tepiH7

Tepi Kemerahan (+)

Count 0 2 4 6

% within Kelompok

0,0% 40,0% 80,0% 40,0%

Tepi Kemerahan (-)

Count 5 3 1 9

% within Kelompok

100,0% 60,0% 20,0% 60,0%

Total

Count 5 5 5 15

% within Kelompok

100,0% 100,0% 100,0% 100,0%

tepiH14 * Kelompok Crosstabulation

Kelompok Total

Serbuk Kopi Robusta

Serbuk Basitracin

Kontrol

tepiH14

Tepi Kemerahan (+)

Count 1 5 1 7

% within Kelompok

20,0% 100,0% 20,0% 46,7%

Tepi Kemerahan (-)

Count 4 0 4 8

% within Kelompok

80,0% 0,0% 80,0% 53,3%

Total

Count 5 5 5 15

% within Kelompok

100,0% 100,0% 100,0% 100,0%

(5)

Crosstabs

Case Processing Summary Cases

Valid Missing Total

N Percent N Percent N Percent

LeukositH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%

LeukositH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%

LeukositH7 * Kelompok Crosstabulation

Kelompok Total

Serbuk Kopi Robusta

Serbuk Basitracin

Kontrol

LeukositH7 Normal

Count 5 5 5 15

% within Kelompok 100,0% 100,0% 100,0% 100,0%

Total

Count 5 5 5 15

% within Kelompok 100,0% 100,0% 100,0% 100,0%

LeukositH14 * Kelompok Crosstabulation

Kelompok Total

Serbuk Kopi Robusta

Serbuk Basitracin

Kontrol

LeukositH14 Normal

Count 5 5 5 15

% within Kelompok 100,0% 100,0% 100,0% 100,0%

Total

Count 5 5 5 15

% within Kelompok 100,0% 100,0% 100,0% 100,0%

Means

Case Processing Summary Cases

Included Excluded Total

N Percent N Percent N Percent

BesarlukaH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%

BesarLukaH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%

(6)

Report

Kelompok BesarlukaH7 BesarLukaH14

Serbuk Kopi Robusta

Mean 1,7000 ,5200

Std. Deviation ,10000 ,13038

Median 1,7000 ,5000

Minimum 1,60 ,40

Maximum 1,80 ,70

Serbuk Basitracin

Mean 1,7800 ,8000

Std. Deviation ,08367 ,10000

Median 1,8000 ,8000

Minimum 1,70 ,70

Maximum 1,90 ,90

Kontrol

Mean 3,2020 1,0400

Std. Deviation ,15007 ,11402

Median 3,2300 1,0000

Minimum 3,06 ,90

Maximum 3,42 1,20

Total

Mean 2,2273 ,7867

Std. Deviation ,72205 ,24456

Median 1,8000 ,8000

Minimum 1,60 ,40

Maximum 3,42 1,20

(7)

NPar Tests

Kruskal-Wallis Test

Ranks

Kelompok N Mean Rank

oozingH7

Serbuk Kopi Robusta 5 11,00

Serbuk Basitracin 5 9,00

Kontrol 5 4,00

Total 15

oozingH14

Serbuk Kopi Robusta 5 8,00

Serbuk Basitracin 5 8,00

Kontrol 5 8,00

Total 15

tepiH7

Serbuk Kopi Robusta 5 11,00

Serbuk Basitracin 5 8,00

Kontrol 5 5,00

Total 15

tepiH14

Serbuk Kopi Robusta 5 10,00

Serbuk Basitracin 5 4,00

Kontrol 5 10,00

Total 15

LeukositH7

Serbuk Kopi Robusta 5 8,00

Serbuk Basitracin 5 8,00

Kontrol 5 8,00

Total 15

LeukositH14

Serbuk Kopi Robusta 5 8,00

Serbuk Basitracin 5 8,00

Kontrol 5 8,00

Total 15

BesarlukaH7

Serbuk Kopi Robusta 5 4,40

Serbuk Basitracin 5 6,60

Kontrol 5 13,00

Total 15

BesarLukaH14

Serbuk Kopi Robusta 5 3,20

Serbuk Basitracin 5 8,00

Kontrol 5 12,80

Total 15

(8)

Test Statisticsa,b oozingH

7

oozingH1 4

tepiH 7

tepiH1 4

LeukositH 7

LeukositH1 4

BesarlukaH 7

BesarLukaH1 4 Chi-

Square

8,667 ,000 6,222 8,000 ,000 ,000 10,274 11,729

df 2 2 2 2 2 2 2 2

Asymp . Sig.

,013 1,000 ,045 ,018 1,000 1,000 ,006 ,003

a. Kruskal Wallis Test

b. Grouping Variable: Kelompok

NPar Tests (kopi robusta) Wilcoxon Signed Ranks Test

Ranks

N Mean Rank Sum of

Ranks

oozingH14 - oozingH7

Negative Ranks 0a ,00 ,00

Positive Ranks 0b ,00 ,00

Ties 5c

Total 5

tepiH14 - tepiH7

Negative Ranks 1d 1,00 1,00

Positive Ranks 0e ,00 ,00

Ties 4f

Total 5

LeukositH14 - LeukositH7

Negative Ranks 0g ,00 ,00

Positive Ranks 0h ,00 ,00

Ties 5i

Total 5

BesarLukaH14 - BesarlukaH7

Negative Ranks 5j 3,00 15,00

Positive Ranks 0k ,00 ,00

Ties 0l

Total 5

a. oozingH14 < oozingH7 b. oozingH14 > oozingH7 c. oozingH14 = oozingH7 d. tepiH14 < tepiH7 e. tepiH14 > tepiH7 f. tepiH14 = tepiH7

(9)

g. LeukositH14 < LeukositH7 h. LeukositH14 > LeukositH7 i. LeukositH14 = LeukositH7 j. BesarLukaH14 < BesarlukaH7 k. BesarLukaH14 > BesarlukaH7 l. BesarLukaH14 = BesarlukaH7

Test Statisticsa oozingH14 -

oozingH7

tepiH14 - tepiH7 LeukositH14 - LeukositH7

BesarLukaH14 - BesarlukaH7

Z ,000b -1,000c ,000b -2,041c

Asymp. Sig. (2-tailed) 1,000 ,317 1,000 ,041

a. Wilcoxon Signed Ranks Test

b. The sum of negative ranks equals the sum of positive ranks.

c. Based on positive ranks.

NPar Tests (basitracin-neomisin) Wilcoxon Signed Ranks Test

Ranks

N Mean Rank Sum of Ranks

oozingH14 - oozingH7

Negative Ranks 0a ,00 ,00

Positive Ranks 1b 1,00 1,00

Ties 4c

Total 5

tepiH14 - tepiH7

Negative Ranks 3d 2,00 6,00

Positive Ranks 0e ,00 ,00

Ties 2f

Total 5

LeukositH14 - LeukositH7

Negative Ranks 0g ,00 ,00

Positive Ranks 0h ,00 ,00

Ties 5i

Total 5

BesarLukaH14 - BesarlukaH7

Negative Ranks 5j 3,00 15,00

Positive Ranks 0k ,00 ,00

Ties 0l

Total 5

a. oozingH14 < oozingH7 b. oozingH14 > oozingH7 c. oozingH14 = oozingH7 d. tepiH14 < tepiH7

(10)

e. tepiH14 > tepiH7 f. tepiH14 = tepiH7

g. LeukositH14 < LeukositH7 h. LeukositH14 > LeukositH7 i. LeukositH14 = LeukositH7 j. BesarLukaH14 < BesarlukaH7 k. BesarLukaH14 > BesarlukaH7 l. BesarLukaH14 = BesarlukaH7

Test Statisticsa oozingH14 -

oozingH7

tepiH14 - tepiH7 LeukositH14 - LeukositH7

BesarLukaH14 - BesarlukaH7

Z -1,000b -1,732c ,000d -2,121c

Asymp. Sig. (2-tailed) ,317 ,083 1,000 ,034

a. Wilcoxon Signed Ranks Test b. Based on negative ranks.

c. Based on positive ranks.

d. The sum of negative ranks equals the sum of positive ranks.

NPar Tests (kontrol)

Wilcoxon Signed Ranks Test

Ranks

N Mean Rank Sum of Ranks

oozingH14 - oozingH7

Negative Ranks 0a ,00 ,00

Positive Ranks 5b 3,00 15,00

Ties 0c

Total 5

tepiH14 - tepiH7

Negative Ranks 0d ,00 ,00

Positive Ranks 3e 2,00 6,00

Ties 2f

Total 5

LeukositH14 - LeukositH7

Negative Ranks 0g ,00 ,00

Positive Ranks 0h ,00 ,00

Ties 5i

Total 5

BesarLukaH14 - BesarlukaH7

Negative Ranks 5j 3,00 15,00

Positive Ranks 0k ,00 ,00

Ties 0l

Total 5

(11)

a. oozingH14 < oozingH7 b. oozingH14 > oozingH7 c. oozingH14 = oozingH7 d. tepiH14 < tepiH7 e. tepiH14 > tepiH7 f. tepiH14 = tepiH7

g. LeukositH14 < LeukositH7 h. LeukositH14 > LeukositH7 i. LeukositH14 = LeukositH7 j. BesarLukaH14 < BesarlukaH7 k. BesarLukaH14 > BesarlukaH7 l. BesarLukaH14 = BesarlukaH7

Test Statisticsa oozingH14 -

oozingH7

tepiH14 - tepiH7 LeukositH14 - LeukositH7

BesarLukaH14 - BesarlukaH7

Z -2,236b -1,732b ,000c -2,023d

Asymp. Sig. (2-tailed) ,025 ,083 1,000 ,043

a. Wilcoxon Signed Ranks Test b. Based on negative ranks.

c. The sum of negative ranks equals the sum of positive ranks.

d. Based on positive ranks.

Referensi

Dokumen terkait

Rhizobium application could reduce the number of empty pods, where the lowest number of empty pods were found in R2V2 in the introduction of technology package Rhizobium treatment of 10

Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Offi ce on Smoking and